| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.033 | 0.9 |